Starling Oncology, Inc. (STLN)
Nasdaq: STLN · CIK 0001799191 · United States
Every official Starling Oncology, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open STLN filings
Starling Oncology, Inc. documents
- Starling Oncology, Inc. 10-K 2026STLN 10-K 2026: annual report for fiscal 2026
- Starling Oncology, Inc. 10-K 2025STLN 10-K 2025: annual report for fiscal 2025
- Starling Oncology, Inc. 10-K 2024STLN 10-K 2024: annual report for fiscal 2024
- Starling Oncology, Inc. 10-K 2023STLN 10-K 2023: annual report for fiscal 2023
- Starling Oncology, Inc. 10-K 2022STLN 10-K 2022: annual report for fiscal 2022
- Starling Oncology, Inc. 10-Q 2026STLN 10-Q 2026: quarterly report for fiscal 2026
- Starling Oncology, Inc. 10-Q 2025STLN 10-Q 2025: quarterly report for fiscal 2025
- Starling Oncology, Inc. 10-Q 2024STLN 10-Q 2024: quarterly report for fiscal 2024
- Starling Oncology, Inc. 10-Q 2023STLN 10-Q 2023: quarterly report for fiscal 2023
- Starling Oncology, Inc. 10-Q 2022STLN 10-Q 2022: quarterly report for fiscal 2022
- Starling Oncology, Inc. 8-K 2026STLN 8-K 2026: current report for fiscal 2026
- Starling Oncology, Inc. 8-K 2025STLN 8-K 2025: current report for fiscal 2025
- Starling Oncology, Inc. 8-K 2024STLN 8-K 2024: current report for fiscal 2024
- Starling Oncology, Inc. 8-K 2023STLN 8-K 2023: current report for fiscal 2023
- Starling Oncology, Inc. 8-K 2022STLN 8-K 2022: current report for fiscal 2022
- Starling Oncology, Inc. DEF 14A 2026STLN DEF 14A 2026: proxy statement for fiscal 2026
- Starling Oncology, Inc. DEF 14A 2025STLN DEF 14A 2025: proxy statement for fiscal 2025
- Starling Oncology, Inc. DEF 14A 2024STLN DEF 14A 2024: proxy statement for fiscal 2024
- Starling Oncology, Inc. DEF 14A 2023STLN DEF 14A 2023: proxy statement for fiscal 2023
- Starling Oncology, Inc. DEF 14A 2022STLN DEF 14A 2022: proxy statement for fiscal 2022
- Starling Oncology, Inc. Form 4 2026STLN Form 4 2026: insider trading filing for fiscal 2026
- Starling Oncology, Inc. Form 4 2025STLN Form 4 2025: insider trading filing for fiscal 2025
- Starling Oncology, Inc. Form 4 2024STLN Form 4 2024: insider trading filing for fiscal 2024
- Starling Oncology, Inc. Form 4 2023STLN Form 4 2023: insider trading filing for fiscal 2023
- Starling Oncology, Inc. Form 4 2022STLN Form 4 2022: insider trading filing for fiscal 2022
- Starling Oncology, Inc. S-1 2026STLN S-1 2026: registration statement for fiscal 2026
- Starling Oncology, Inc. S-1 2025STLN S-1 2025: registration statement for fiscal 2025
- Starling Oncology, Inc. S-1 2024STLN S-1 2024: registration statement for fiscal 2024
- Starling Oncology, Inc. S-1 2023STLN S-1 2023: registration statement for fiscal 2023
- Starling Oncology, Inc. S-1 2022STLN S-1 2022: registration statement for fiscal 2022
- Starling Oncology, Inc. 13F 2026STLN 13F 2026: institutional holdings for fiscal 2026
- Starling Oncology, Inc. 13F 2025STLN 13F 2025: institutional holdings for fiscal 2025
- Starling Oncology, Inc. 13F 2024STLN 13F 2024: institutional holdings for fiscal 2024
- Starling Oncology, Inc. 13F 2023STLN 13F 2023: institutional holdings for fiscal 2023
- Starling Oncology, Inc. 13F 2022STLN 13F 2022: institutional holdings for fiscal 2022
More companies